This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Key innovation: Leading companies in nanoparticles for drugdelivery. Bristol-Myers Squibb is the leading patent filer in nanoparticles for drugdelivery.
In 1974, Dr. Robert Langer was part of the first cohort of researchers to begin nanoparticle research , as his lab at Cornell University developed tiny particles to deliver large molecules for angiogenesis. Since then, the drug has been used off-label in breast cancer and other types of cancer.
Interest in the pulmonary route has also grown in recent years because delivering the drugs through the lungs allows direct systemic delivery and bypasses the first pass metabolism. Why is pulmonary drugdelivery a complex challenge? How can we accomplish drugdelivery to the lungs in nonclinical studies?
A REVIEW OF MAGNETIC NANOPARTICLES IN TARGETED DRUGDELIVERY admin Mon, 05/29/2023 - 15:04 About Authors CHETNA MODI 1 *, VINIT MODI 2 , SHWETA RAY 2 , PIYUSH NARIYA 2 , VARSHA GADHVI 2 1 Professor, Department of Pharmaceutics, Anand Pharmacy College, Anand, Gujarat, India. chetnamodi306@gmail.com
at Northwestern University—has developed novel technology with the potential to change the future of drugdelivery. A team of scientists—led by Yamin Zhang, Ph.D., and Colin Franz, MD, Ph.D., at Shirley Ryan AbilityLab and John Rogers, Ph.D.,
The next time you need to take a prescription drug, taking it might be as easy as putting on a contact lens, thanks to a new discovery made by University of Waterloo researchers.
Treating diseases such as Alzheimer’s or Parkinson’s is a challenge because drugs have to be able to cross the blood–brain barrier. To solve this issue, the postdoctoral researcher Jean-Michel Rabanel, […].
Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily eye drops to treat glaucoma, a leading cause of blindness.
Similarly, the target delivery approach in healthcare would take the drugs directly to right where it’s needed: the disease site, icing apt treatment. We have put in our best effort to make it easily graspable what are the intracellular drugdelivery technologies and how it can ensure effective treatment for fatal disease.
— University of Louisville researchers have found a less toxic way to deliver medicines by using the natural lipids in plants, particularly grapefruit and ginger. Suite of technologies now has commercial partner to bring them to market Credit: University of Louisville LOUISVILLE, Ky.
It has combined expertise in otology, gene therapy and inner ear drugdelivery to meet the requirements of individuals with disabling hearing loss globally. Akouos focuses on developing adeno-associated viral gene therapies to treat inner ear conditions, including sensorineural hearing loss.
According to Precedence Research, the global injectable drugdelivery market reached U.S. Simplifying the administration of complex injectables for reconstitution, liquid/liquid mixing and the sequential delivery of multiple liquid drugs.
Interestingly, over the past few years, drug developers focused on non-respiratory diseases have also shifted their attention towards intranasal drug formulations. This can be attributed to ease of delivery, increased bioavailability and by-pass of first-pass metabolism offered by this type of route of administration.
Sorrento Technologies, a biotech firm developing novel treatments for COVID-19 and aggressive cancers such as melanoma, has received FDA clearance to start a research collaboration together with Mayo Clinic.
North America DrugDelivery Market Research Report 2021 with Forecasts to 2026 – ResearchAndMarkets.com North America DrugDelivery Market Research Report 2021 with Forecasts to 2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “North America DrugDelivery Market – Forecasts from 2021 to … Continue reading (..)
Federally funded study says drugdelivery for certain common eye diseases could be improved Credit: University of Cincinnati Getting poked in the eye with a sharp object is a cringeworthy thought.
World Leading DrugDeliveryResearcher Professor Ryan Donnelly Joins PharmaTher as Scientific and Technical Advisor World Leading DrugDeliveryResearcher Professor Ryan Donnelly Joins PharmaTher as Scientific and Technical Advisor Focus on expanding the delivery of controlled-substances in a microneedle … Continue reading →
The drugdelivery platform company is exploring the viability of remdesivir and other potential treatments for the virus using its DehydraTECH technology.
The repurposing of FDA-approved drugs for alternative diseases is a faster way of bringing new treatments into the clinic. Researchers at Karolinska Institutet in Sweden have repurposed a cancer drug for treatment of neuroinflammatory diseases such as multiple sclerosis.
Nanoscale machinery has many uses, including drugdelivery, single-atom transistor technology, or memory storage. However, the machinery must be assembled at the nanoscale which is a considerable challenge for researchers.
Collaboration of researchers will improve imaging methods to assess extent of drugdelivery to the skin – including creams and lotions for conditions like eczema
Global Transdermal DrugDelivery Systems Market Research Report 2021: Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2015-2020 & 2021-2026 – ResearchAndMarkets.com Global Transdermal DrugDelivery Systems Market Research Report 2021: Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2015-2020 … Continue (..)
Dill/NIST In a technique known as DNA origami, researchers fold long strands of DNA over and over again to construct a variety of tiny 3D structures, including miniature biosensors and drug-delivery containers.
The 2024 ASCO Annual Meeting from the American Society of Clinical Oncology is a fantastic platform for clinical researchers to discuss the latest advancements and challenges in oncology research. Currently, there are 12 approved ADC drugs, and several hundred more are in the development pipeline.
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Nanosyrinx raises £6.2m to validate drugdelivery platform. from European Biotechnology – first and foremost in European biotech [link].
In a significant move set to reshape the landscape of drug discovery, NovAliX, a leading Contract Research Organization (CRO) specializing in drug development, has entered a strategic partnership with Bruker, a global leader in scientific instruments.
Ceapro has extended a partnership underway to carry out a further research project with McMaster University for developing an inhalable immuno-therapeutic/-prophylactic for Covid-19-induced lung fibrosis. This project is intended to develop therapies for people suffering from Covid-19’s long-term effects.
KBI Biopharma, Veranova and Kindeva DrugDelivery are among the companies welcoming new faces to top jobs. Bio Pharma Reporter and Outsourcing Pharma is back with our latest instalment of movers and shakers - breaking down all the key pharma industry appointments that you should know about.
Researchers at ETH Zurich have developed a method for concentrating and releasing drugs in the brain with pinpoint accuracy. This could make it possible in the future to deliver psychiatric and cancer drugs and other medications only to those regions of the brain where this is medically desirable.
In a promising advancement, scientists from the University of North Carolina at Chapel Hill and Emory University have developed a novel drugdelivery system using synthetic amyloid beta (AÎ) peptides.
When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. By having the drug already dosed inside the chamber and no need to draw it from a vial into a syringe, the process is streamlined and the risk of a potential dosing error is eliminated.
An international team led by a Skoltech researcher has developed a method of fabrication for biodegradable polymer microcapsules, made more efficient by turning to an unusual source of inspiration – traditional Russian dumpling, or pelmeni, making. Micro-sized capsules, which can […].
To sum it, Chinook will manage clinical development and commercialization of product candidates while Evotec will be eligible for an undisclosed upfront payment, research funding, progress-dependent milestone payments, and tiered royalties on net sales for targets identified through the collaboration.
The company will undertake a technology transfer and feasibility study for a drug product focused on the treatment of IPF at its centre of cell and gene expertise in Milan, Italy. We welcome the opportunity to help further the important work of the Jikei University in Japan, a historic research and medical institute.
Samyang Holdings Biopharm Division CEO Young-Joon Lee stated: “LG Chem has exceptional research and development expertise in innovative drug development and a number of promising new drug pipelines. This is expected to shorten the development time of new drugs and to support personalised treatments.
Ophthalmic Drugs Conference. Delving into advanced R&D and Delivery of Ocular Therapeutics. SAE Media Group’s 5th Annual Ophthalmic Drugs Conference will explore advancements in ophthalmic treatments and variety of novel drugs, which are showing good clinical trial data. SAE Media Group’s 5th Annual.
Now research reveals that bacteria too have internal clocks that align with the 24-hour cycle of life on Earth. The research answers a long-standing biological question and could have implications for the timing of drugdelivery, biotechnology, and […].
The rankings are based on each companys ability to tackle critical challenges from drugdelivery and diagnostics to personalized therapies using cutting-edge science. Recursion Recursion launched the LOWE AI-driven drug discovery platform, reporting $51.1 Here are 20 companies leading the way in 2025.
Sited in Pennsylvania, the excipients specialistâs new facility reportedly will work toward advancing drugdeliveryresearch and boosting speed to market.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content